The proposed dosage of CAPLYTA is forty two mg administered orally at the time every day with or without having foods. Dose titration is just not expected.Concomitant usage of CAPLYTA with average or robust CYP3A4 inhibitors raises lumateperone exposure [see CLINICAL PHARMACOLOGY], which can improve the threat of adverse reactions.Whilst we're unab